GSK’s Shingrix is latest drug to show potential for targeting previously untreatable brain disorders
Letter to prime minister seeks boost for new science and tech ‘supercluster’ after plans stalled under previous government
Pharma groups could see almost threefold drop in demand due to US health official decision, says Airfinity
Swiss drugmaker says it will only sell medication privately if health systems cannot pay
Pharma group seeks to catch up with rivals Eli Lilly and Novo Nordisk in sector projected to be worth $130bn a year
New compound increases strength of antidote for fentanyl and other lethal drugs
New drug Kisunla will be 20% more than rival as drugmaker claims it requires fewer treatments
Federal health officials step up efforts to boost jab stockpiles in response to widening outbreak
More detail and less ‘soundbites’ needed to unlock the sector’s economic potential, say science and tech groups
Move opens market with growing rates of obesity to Danish group’s blockbuster drug
Danish pharma group plans 1.4mn sq ft manufacturing plant in North Carolina to help meet surging demand
Oral formulation offers prospect of cheaper and more convenient access to drug, research suggests
Vutrisiran injection cut risk of death and adverse cardiovascular events by at least 28%, company says
Launch highlights growth of venture philanthropy to boost search for treatments and cures
As incidence rises, breakthroughs in oncology show the value of research funding
Both OZEM and THNR offer very concentrated bets on a fast-moving market
‘Gene desert’ research boosts knowledge of chronic disease mechanisms and promises to unlock novel therapies
US decision hands biotech group its first regulatory blessing since its blockbuster Covid-19 jab
US group hopes EyeBio will refill its pipeline with treatments targeting causes of blindness
US drugmaker races to scale up ingredient production to meet demand for Mounjaro and Zepbound jabs
As Covid revenues slump, technology developed to fight the pandemic is having some success combating this disease
The sector’s holy grail of an effective, easily manufactured weight loss pill does not look imminent
There’s an arms race in academic publishing between AI, fraud detectors and authorship brokers
Weekly injection delivered 18.8% weight loss over 24 weeks
Study opens up potential to tackle a condition with few available treatment options